Psychometric Properties of the Chinese Version of the Functional Assessment of Chronic Illness Therapy - Palliative Care (FACIT-Pal) in Patients With Advanced Cancer.
Xiaojun Zhou, Xia Tian, Yidan Fan...
https://pubmed.ncbi.nlm.nih.gov/37769823Actively Recruiting
Led by The University of Hong Kong · Updated on 2025-04-02
280
Participants Needed
1
Research Sites
8 weeks
Total Duration
Researchers are evaluating a communication-priming intervention called "CKD Jumpstart- Tips" aimed at improving shared decision-making between older adults with advanced chronic kidney disease (CKD) and their clinicians. This cluster-randomized controlled trial focuses on patients with CKD Stage 4 or 5, seeking to enhance communication quality, patient involvement, decisional conflict, decision regret, timing and adherence to treatment choices, and health-related quality of life. The study compares two groups: one receiving the "CKD Jumpstart- Tips" intervention and the other receiving usual care. Patients in the intervention group complete the priming tool before a target clinic visit and receive a summary sheet with communication tips and survey responses to share with their healthcare team. Clinicians also receive a priming sheet with tailored communication guidance based on patient responses. Additional educational materials on kidney failure treatment options are available as part of routine care. Participants will be assessed immediately after the target visit and followed for up to six months. Evaluations include observer-rated and patient-reported shared decision-making, quality of communication, consultation length, patient involvement, decisional conflict and regret, timing and adherence to treatment, and health-related quality of life. The study aims to measure the impact of the communication intervention on these outcomes while monitoring patient experience and treatment decisions over time.
CONDITIONS
A Communication-Priming Intervention to Improve Shared Decision-Making Between Older Adults With Advanced CKD and Clinicians
You may qualify if you...
You will not qualify if you...
Complete this quick 3-step screening to check your eligibility
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person or phone)
Duration - Within 1 week before and on the day of the target clinic visit
Participants in the priming intervention arm complete a communication priming tool before a target clinic visit. They receive a summary sheet with their survey responses and communication tips to use during the visit. Clinicians also receive tailored communication tips before and on the day of the visit.
1 baseline visit (target clinic visit)
Duration - Up to 6 months after the target clinic visit
Participants complete follow-up assessments on decisional conflict, decisional regret, timing and adherence to treatment choice, and health-related quality of life after the target clinic visit.
3 follow-up visits (immediately after, 3 months, and 6 months post-visit)
Total: 1 location
1
Queen Mary Hospital
Hong Kong, Hong Kong
Actively Recruiting
J
Jacqueline KY Yuen, Dr
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
HEALTH_SERVICES_RESEARCH
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Xiaojun Zhou, Xia Tian, Yidan Fan...
https://pubmed.ncbi.nlm.nih.gov/37769823Richard Huan Xu, Ling Ming Zhou, Eliza Laiyi Wong...
https://pubmed.ncbi.nlm.nih.gov/33424697Jamie C Brehaut, Annette M O'Connor, Timothy J Wood...
https://pubmed.ncbi.nlm.nih.gov/12926578Wendy W T Lam, Marie Kwok, Qiuyan Liao...
https://pubmed.ncbi.nlm.nih.gov/23167846A M O'Connor
https://pubmed.ncbi.nlm.nih.gov/7898294Glyn Elwyn, Neeltje Petronella Catharina Anna Vermunt
https://pubmed.ncbi.nlm.nih.gov/33294602Kirsten J McCaffery, Margaret Holmes-Rovner, Sian K Smith...
https://pubmed.ncbi.nlm.nih.gov/24624970Karen R Sepucha, Cornelia M Borkhoff, Joanne Lally...
https://pubmed.ncbi.nlm.nih.gov/24625035Janet L Davis, Sara N Davison
https://pubmed.ncbi.nlm.nih.gov/28212179Rachael Morton
https://pubmed.ncbi.nlm.nih.gov/27385805